# Domperidone

## Wempty 1mg/mL 60mL suspension

| 藥物代碼 | LWEM |
| :--- | :--- |
| 適應症 | Symptomatic treatment of nausea & vomiting, diabetic gastroparesis. |
| 副作用 | Rarely hypersensitivity reactions, raised serum prolactin levels, extrapyramidal reactions; GI abnormalities, urticaria, galactorrhea, gynecomastia, menstrual irregularity. |
| 禁忌 | Prolactinoma; co-administration with ketoconazole; GI hemorrhage, mechanical obstruction, perforation. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult & children &gt; 12 years & &gt; 35 kg 10 mg qd-tid. Children &lt; 12yr or body weight &lt; 35kg: 0.25 mg/kg qd-tid. |
| 肝功能異常 | 無需調整劑量  中度或重度嚴重肝功能障礙者不建議使用 |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

## Domper 10mg

| 藥物代碼 | ODOM |
| :--- | :--- |
| 適應症 | Nausea and vomiting or GI motility disorder |
| 副作用 | 1% to 10%:Central nervous system: Headache, migraineGastrointestinal: Xerostomia&lt;1%, postmarketing, and/or case reports: Abdominal cramps, acid regurgitation, change in appetite, conjunctivitis, constipation, diarrhea, dizziness, dysuria, edema, extrapyramidal reaction \(rare\), galactorrhea, gynecomastia, heartburn, hot flash, increased serum ALT, increased serum AST, increased serum cholesterol, increased serum prolactin, increased thirst, insomnia, irritability, leg cramps, lethargy, mastalgia, menstrual disease, nausea, nervousness, palpitations, pruritus, skin rash, stomatitis, torsades de pointes, urinary frequency, urticaria, weakness |
| 禁忌 | Hypersensitivity to domperidone or any component of the formulation; prolactin-releasing pituitary tumor \(prolactinoma\); known existing prolongation of cardiac conduction intervals, particularly QT; significant electrolyte disturbances; underlying cardiac disease \(eg, heart failure\); moderate or severe hepatic impairment; patients with GI hemorrhage, mechanical obstruction, or perforation; concomitant use with potent CYP3A4 inhibitors such as azole antifungals \(eg, ketoconazole\), macrolides \(eg, erythromycin\), protease inhibitors, or nefazodone; concomitant use with QT-prolonging drugs |
| 藥物保存方式 | 室溫 |
| 用法用量 | Adult: 10 mg tid. Max: 30 mg daily. Child:&gt;12 yr &lt;35 kg: 0.25mg/kg up to tid daily. |
| 肝功能異常 | 需 調 整 劑 量  Moderate to severe: Contraindicated. |
| 腎功能異常 | 需 調 整 劑 量 |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

